Pricing Log in Create free account
Friday 6 November 2026 Export TEM’s income statement to Excel — free account

Tempus AI, Inc.

TEM Healthcare Health Information Services

Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.

Revenue
+23.1%
EPS
+82.2%
Free cash flow
+95.7%
Total debt
+8.44%

Quarter to September 2026, against a year earlier

76.30 5.87 +8.33%
Market cap
$12.9B
P/E
0.0×
Fwd P/E
−51.8×
Dividend yield
—
F-score
4/9
Altman Z
2.60
Beneish M
−1.25
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Tempus AI, Inc. 10-Q filed Jul 30, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed · accepted 4:03 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 5, 2026: 35 added · 5 removed · 62 modified; 13 with only figures updated; 2 moved without change

  1. Modified · Overview

    We primarily operate in the United States and generated total revenue of $348.1382.5 million and $255.7314.6 million in the three months ended March 31June 30, 2026 and 2025, respectively, and $730.6 million and $570.4 million in the six months ended June 30, 2026 and 2025, respectively. We also incurred net income (losses) of $125.95.6 million and $68.0(42.8) million in the three months ended March 31June 30, 2026 and 2025, respectively. We generated adjusted EBITDA of , and $(2.8120.3) million and $(16.2110.9) million in the threesix months ended March 31June 30, 2026 and 2025, respectively. Adjusted We generated adjusted EBITDA is a non-GAAP financial measure. For a reconciliation of adjusted EBITDA to net lossof $8.0 million and $(5.6) million in the three months ended June 30, 2026 and 2025, the most directly comparable financial measure statedrespectively, and $5.2 million and $(21.8) million in accordance with generally accepted accounting principles in the United States of America, or GAAP, and for additional information about the six months ended June 30, 2026 and 2025, respectively. Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation of adjusted EBITDA, a non-GAAP financial measure to net income (loss), see "—Non-GAAP Financial Measure."the most directly comparable financial measure